Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Net Income - Minority (2019)

Lisata Therapeutics filings provide 3 years of Net Income - Minority readings, the most recent being $263000.0 for Q4 2019.

  • On a quarterly basis, Net Income - Minority changed N/A to $263000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $263000.0, a N/A change, with the full-year FY2019 number at $263000.0, changed N/A from a year prior.
  • Net Income - Minority hit $263000.0 in Q4 2019 for Lisata Therapeutics, up from -$5.5 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of $263000.0 in Q4 2019 to a low of $263000.0 in Q4 2019.